Recursion PharmaceuticalsRXRX
那斯達克 · USD
5.68
-0.27
(-4.54%)
收盤 08/02 03:59 (UTC+8)
盤後
5.63
5.63
(-0.88%)
08/02 03:59 (UTC+8)
Recursion PharmaceuticalsRXRX
5.68
-0.27
(-4.54%)
財務數據
損益表
- 0.14
- 0.12
- 0.11
- 0.11
- 0.11
- 0.14
- 0.14
- 0.26
- 0.05
- 0.15
- 3.92
- -11.28
- -9.21
- -4.39
- 3.40
- 26.66
- 4.52
- 80.91
- -82.57
- 224.35
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 14,745 | 4,546 | 26,082 | 14,417 | 13,794 | 10,891 | 10,533 | 11,017 | 12,134 | 13,676 |
營業成本 | 21,829 | 12,794 | 12,079 | 9,199 | 11,166 | 9,881 | 10,877 | 9,381 | 12,448 | 10,840 |
營業毛利 | -7,084 | -8,248 | 14,003 | 5,218 | 2,628 | 1,010 | -344 | 1,636 | -314 | 2,836 |
營業費用 | 184,284 | 175,520 | 112,356 | 105,761 | 98,968 | 99,940 | 99,206 | 83,351 | 69,551 | 63,818 |
研發費用 | 129,634 | 98,334 | 74,599 | 73,928 | 67,560 | 69,482 | 70,007 | 55,060 | 46,677 | 43,980 |
推銷及管理費用 | 54,650 | 77,186 | 37,757 | 31,833 | 31,408 | 30,458 | 29,199 | 28,291 | 22,874 | 19,838 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -191,368 | -183,768 | -98,353 | -100,543 | -96,340 | -98,930 | -99,550 | -81,715 | -69,865 | -60,982 |
其他收入及費用 | -11,277 | 4,869 | 2,679 | 2,480 | 4,188 | 1,872 | 6,533 | 4,989 | 4,538 | 3,490 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -202,645 | -178,899 | -95,674 | -98,063 | -92,152 | -97,058 | -93,017 | -76,726 | -65,327 | -57,492 |
所得稅 | -158 | 7 | 168 | -523 | -779 | -4,062 | - | - | - | - |
稅後純益 | -202,487 | -178,906 | -95,842 | -97,540 | -91,373 | -92,996 | -93,017 | -76,726 | -65,327 | -57,492 |
基本每股稅後盈餘(元) | -0.50 | -0.53 | -0.34 | -0.40 | -0.39 | -0.42 | -0.43 | -0.38 | -0.34 | -0.31 |
稀釋每股稅後盈餘(元) | -0.50 | -0.57 | -0.33 | -0.40 | -0.39 | -0.42 | -0.45 | -0.37 | -0.34 | -0.30 |
基本平均股數(千股) | 402771.00 | 336035.00 | 282583.00 | 242196.00 | 236019.00 | 223158.00 | 214327.00 | 201415.00 | 191618.00 | 185669.00 |
稀釋平均股數(千股) | 402771.00 | 336035.00 | 282583.00 | 242196.00 | 236019.00 | 223158.00 | 214327.00 | 201415.00 | 191618.00 | 185669.00 |
還原基本每股稅後盈餘(元) | -0.50 | -0.53 | -0.34 | -0.40 | -0.39 | -0.42 | -0.43 | -0.38 | -0.34 | -0.31 |
還原稀釋每股稅後盈餘(元) | -0.50 | -0.57 | -0.33 | -0.40 | -0.39 | -0.42 | -0.45 | -0.37 | -0.34 | -0.30 |
還原基本平均股數(千股) | 402,771 | 336,035 | 282,583 | 242,196 | 236,019 | 223,158 | 214,327 | 201,415 | 191,618 | 185,669 |
還原稀釋平均股數(千股) | 402,771 | 336,035 | 282,583 | 242,196 | 236,019 | 223,158 | 214,327 | 201,415 | 191,618 | 185,669 |
EBITDA(千元) | -183,314 | -165,948 | -88,476 | -89,095 | -84,775 | -89,505 | -85,439 | -71,183 | -61,599 | -54,278 |